Composition
- Active ingredients
- OXALIPLATIN 50MG/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- OXALIPLATIN 50MG/10ML (5MG/ML) · InjectableANDA078811-001 · Prescription
- OXALIPLATIN 100MG/20ML (5MG/ML) · InjectableANDA078811-002 · Prescription
- OXALIPLATIN 100MG/VIAL · InjectableANDA078818-002 · Discontinued
- OXALIPLATIN 50MG/VIAL · InjectableANDA078818-001 · Discontinued
- OXALIPLATIN 200MG/40ML (5MG/ML) · InjectableANDA202922-003 · Discontinued
- OXALIPLATIN 50MG/10ML (5MG/ML) · InjectableANDA202922-001 · Discontinued
- OXALIPLATIN 100MG/20ML (5MG/ML) · InjectableANDA202922-002 · Discontinued
- OXALIPLATIN 50MG/VIAL · InjectableANDA078819-001 · Prescription
- OXALIPLATIN 100MG/VIAL · InjectableANDA078819-002 · Prescription
- OXALIPLATIN 100MG/20ML (5MG/ML) · InjectableANDA091358-002 · Prescription
- OXALIPLATIN 200MG/40ML (5MG/ML) · InjectableANDA091358-003 · Discontinued
- OXALIPLATIN 50MG/10ML (5MG/ML) · InjectableANDA091358-001 · Prescription
- OXALIPLATIN 50MG/VIAL · Injectable
At a glance
- Brand name
- Oxaliplatin
- Route
- Intravenous
- Dosage form
- Injectable
- Applicant
- Fresenius Kabi Oncol
- Status
- Discontinued
- FDA approval
- 7 Aug 2009
- Application
- ANDA078810-001